Navigation Links
Commonly used painkillers may protect against skin cancer
Date:5/28/2012

A new study suggests that aspirin and other similar painkillers may help protect against skin cancer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings indicate that skin cancer prevention may be added to the benefits of these commonly used medications.

Previous studies suggest that taking nonsteroidal anti-inflammatory drugs, or NSAIDs, which include aspirin, ibuprofen, and naproxen, as well as a variety of other nonprescription and prescription drugs, can decrease an individual's risk of developing some types of cancer. Sigrn Alba Jhannesdttir, BSc, of Aarhus University Hospital in Denmark, and her colleagues looked to see if the medications might decrease the risk of the three major types of skin cancer: basal cell carcinoma, squamous cell carcinoma, and malignant melanoma.

The researchers analyzed medical records from northern Denmark from 1991 through 2009 and identified 1,974 diagnoses of squamous cell carcinoma, 13,316 diagnoses of basal cell carcinoma, and 3,242 diagnoses of malignant melanoma. They compared information, including prescription data, from these patients with information from 178,655 individuals without skin cancer.

Individuals who filled more than two prescriptions for NSAIDs had a 15 percent decreased risk for developing squamous cell carcinoma and a 13 percent decreased risk for developing malignant melanoma than those who filled two or fewer prescriptions for the medications, especially when the drugs were taken for seven or more years or taken at high intensity. Individuals who took NSAIDs did not seem to benefit from a reduced risk of developing basal cell carcinoma in general, although they did have a 15 percent and 21 percent reduced risk of developing this type of cancer on less-exposed sites (body areas other than the head and neck) when they took them long term or at high intensity, respectively.

"We hope that the potential cancer-protective effect of NSAIDs will inspire more research on skin cancer prevention," said Ms. Jhannesdttir. "Also, this potential cancer-protective effect should be taken into account when discussing benefits and harms of NSAID use."


'/>"/>
Contact: Amy Molnar
healthnews@wiley.com
Wiley-Blackwell
Source:Eurekalert

Related medicine news :

1. Study shows PRP, commonly used technique to improve healing, doesnt work in rotator cuff surgery
2. Commonly used defibrillators raise risk of problems
3. Commonly used supplement may improve recovery from spinal cord injuries
4. Commonly used 3-drug regimen for idiopathic pulmonary fibrosis found harmful
5. Study helps eliminate causes for joint pain linked to commonly used breast cancer drugs
6. Painkillers Lower Estrogen Levels, May Explain Cancer Reduction Risk
7. Another perk of painkillers? Decreased hormone levels may reduce cancer risk
8. Statins, Painkillers May Upset PSA Test Results
9. Painkillers in Pregnancy May Harm Sons Fertility, Study Suggests
10. Prescriptions for Stimulants, Painkillers Soaring Among Youth
11. Oxycontin, Other Opioid Painkillers Tied to Higher Health Risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... ... September 25, 2017 , ... Bobbie Horowitz was hardly able to walk without ... As a cabaret and theater producer, Horowitz would manage to get to rehearsals on ... New York City, so she had to take a cab everywhere. , It ...
(Date:9/25/2017)... ... September 25, 2017 , ... ... clinical research, today announces that 30 of its domain experts will present ... lifecycle at upcoming industry conferences and webinars. Drawing on broad and deep ...
(Date:9/25/2017)... ... , ... Physician Partners of America announces that Chad Gorman, M.D., has joined ... pain management specialist. , Dr. Gorman is a board-certified physician specializing in treating ... Brooksville, Fla. His orthopedic background puts him in a unique position to treat complex ...
(Date:9/25/2017)... York (PRWEB) , ... September 25, 2017 , ... ... & Microsurgery Institute is excited to announce the next generation for LASIK in ... is one of the most technologically advanced laser systems available in the United ...
(Date:9/25/2017)... ... , ... Dr. Edward Hebert is celebrating his 33rd anniversary as ... said Dr. Hebert. “I count my blessings daily for the opportunity that the field ... what I look forward to the most. The relationships I have with my patients ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... --  BioLife Solutions , Inc. (NASDAQ: BLFS ), ... cell and tissue hypothermic storage and cryopreservation ... President and CEO, will be presenting at two investment conferences ... 19 th Annual Global Investment Conference on Tuesday, September ... The conference is being held at the New York Palace ...
(Date:9/6/2017)... , Sept. 6, 2017   PDI , a ... it will host an educational session focused on the ... infection (CLABSI) prevention at the 2017 Annual Scientific Meeting ... will take place at the Phoenix ... from Sept. 16-19, will also feature PDI,s ...
(Date:9/5/2017)... Colo. , Sept. 5, 2017 Sapheneia ... XR-29 DoseCheck solution. Scannerside DoseCheck is a third-party Vendor ... existing CT scanners and allows compliance with current MITA ... Sapheneia-Scannerside proprietary XR 29 DoseCheck solution is specifically designed ... and alerts of potential radiation doses over a predefined ...
Breaking Medicine Technology: